Race Oncology Begins Patient Enrollment at Second Site of RC220 Solid Tumor Clinical Trial

MT NewswiresApr 21 19:48 ET

Race Oncology Begins Patient Enrollment in Australia for RC220 Phase 1 Clinical Trial; Shares Up 6%

MT NewswiresApr 2 20:19 ET

Race Oncology Secures Human Ethics Approval for Phase 1 RC220 Trial in Combination With Doxorubicin | ASX:RAC, OTC:RAONF

Proactive InvestorsMar 31 18:13 ET

Race Oncology Obtains Human Ethics Approval for Phase 1 Clinical Trial at Gosford, Wyong Hospitals in New South Wales

MT NewswiresMar 31 18:03 ET

Race Oncology Initiates First Australian Site for Advanced Solid Tumor Study

MT NewswiresMar 27 23:51 ET

Daniel Tillett on Race Oncology's Drug Advancements | ASX:RAC, OTC:RAONF

Proactive InvestorsMar 20 20:09 ET